Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis

被引:10
|
作者
Veyrard, Pauline [1 ]
Pellet, Gauthier [2 ]
Laharie, David [2 ]
Nachury, Maria [3 ]
Juillerat, Pascal [4 ]
Roblin, Xavier [5 ]
机构
[1] CHU St Etienne, Dept Gastroenterol, Clin Mutualiste, St Etienne, France
[2] Univ Bordeaux, Hop Haut Leveque, Ctr Med Chirurg Magellan, Dept Gastroenterol & Hepatol,INSERM,CIC 1401, Bordeaux, France
[3] Univ Lille, CHU Lille, INFIN Inst Translat Res Inflammat, Inserm,U1286, Lille, France
[4] Bern Univ Hosp, Inselspital, Clin Visceral Surg & Med, Bern, Switzerland
[5] CHU St Etienne, Dept Gastroenterol, St Etienne, France
关键词
D O I
10.1016/j.cgh.2022.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1354 / 1355
页数:2
相关论文
共 50 条
  • [1] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis
    Veyrard, P.
    Pellet, G.
    Laharie, D.
    Nachury, M.
    Juillerat, P.
    Altwegg, R.
    Nancey, S.
    Fumery, M.
    Allez, M.
    Minh, M. L. Tran
    Roblin, X.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I389 - I390
  • [2] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis
    Veyrard, P.
    Pellet, G.
    Laharie, D.
    Nachury, M.
    Juillerat, P.
    Altwegg, R.
    Nancey, S.
    Fumery, M.
    Allez, M.
    Minh, M. L. Tran
    Roblin, X.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I389 - I390
  • [3] EFFICACY AND SAFETY OF INDUCTION THERAPY WITH CALCINEURIN INHIBITORS IN COMBINATION WITH USTEKINUMAN FOR ACUTE SEVERE COLITIS
    Veyrard, Pauline
    Pellet, Gauthier
    Laharie, David
    Nachury, Maria
    Juillerat, Pascal
    Altwegg, Romain
    Nancey, Stephane
    Fumery, Mathurin
    Allez, Matthieu
    Tran-Minh, My-Linh
    Roblin, Xavier
    GASTROENTEROLOGY, 2022, 162 (07) : S992 - S992
  • [4] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [5] Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis
    Dwadasi, Sujaata
    Zafer, Maryam
    Goens, Donald
    Paknikar, Raghavendra
    Dalal, Sushila
    Cohen, Russell D.
    Pekow, Joel
    Rubin, David T.
    Sakuraba, Atsushi
    Micic, Dejan
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : 1620 - 1625
  • [6] Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis
    Nguyen, Khue M.
    Wright, Emily K.
    ACG CASE REPORTS JOURNAL, 2024, 11 (03)
  • [7] SYSTEMATIC REVIEW OF CALCINEURIN INHIBITORS (CNI) AND VEDOLIZUMAB (VDZ) COMBINATION THERAPY IN ACUTE SEVERE ULCERATIVE COLITIS (ASUC)
    Lin, Huiyu
    Lim, Wee Chian
    GUT, 2019, 68 : A96 - A96
  • [8] Systematic review of calcineurin inhibitors (CNI) and vedolizumab (VDZ) combination therapy in acute severe ulcerative colitis (ASUC)
    Lin, H.
    Lim, W. -C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S374 - S375
  • [9] Combination therapy for acute severe ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 112 - 112
  • [10] Efficacy of Vedolizumab and Ustekinumab Following Cyclosporine Induction in Acute Severe Ulcerative Colitis: A Retrospective Cohort Study
    Harb, M.
    Bazin, T.
    Solene, D.
    Bresteau, C.
    El Khatib, M.
    Bourdillel, J.
    Colas, C.
    Corcos, O.
    Billiauws, L.
    Joly, F.
    Nuzzo, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1260 - i1260